134 related articles for article (PubMed ID: 32925511)
1. Survival patterns of childhood neuroblastoma: an analysis of clinical data from Southern-Eastern European countries.
Karalexi MA; Servitzoglou M; Papadakis V; Kachanov D; Česen Mazič M; Baka M; Moschovi M; Kourti M; Polychronopoulou S; Stiakaki E; Hatzipantelis E; Dana H; Stefanaki K; Malama A; Themistocleous MS; Strantzia K; Shamanskaya T; Bouka P; Panagopoulou P; Kantzanou M; Ntzani E; Dessypris N; Petridou ET
Eur J Cancer Prev; 2023 May; 32(3):254-263. PubMed ID: 32925511
[TBL] [Abstract][Full Text] [Related]
2. Wilms tumour event-free and overall survival in Southern and Eastern Europe: Pooled analyses of clinical data from four childhood cancer registries (1999-2017).
Doganis D; Zborovskaya A; Trojanowski M; Zagar T; Bouka P; Baka M; Moschovi M; Polychronopoulou S; Papakonstantinou E; Tragiannidis A; Stiakaki E; Dana H; Stefanaki K; Strantzia K; Kochubinsky D; Marciniak P; Avcin S; Antoniadi K; Dessypris N; Petridou ET
Eur J Cancer; 2019 Jul; 115():37-46. PubMed ID: 31082691
[TBL] [Abstract][Full Text] [Related]
3. Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641.
Strother DR; London WB; Schmidt ML; Brodeur GM; Shimada H; Thorner P; Collins MH; Tagge E; Adkins S; Reynolds CP; Murray K; Lavey RS; Matthay KK; Castleberry R; Maris JM; Cohn SL
J Clin Oncol; 2012 May; 30(15):1842-8. PubMed ID: 22529259
[TBL] [Abstract][Full Text] [Related]
4. Persisting inequalities in survival patterns of childhood neuroblastoma in Southern and Eastern Europe and the effect of socio-economic development compared with those of the US.
Panagopoulou P; Georgakis MK; Baka M; Moschovi M; Papadakis V; Polychronopoulou S; Kourti M; Hatzipantelis E; Stiakaki E; Dana H; Tragiannidis A; Bouka E; Antunes L; Bastos J; Coza D; Demetriou A; Agius D; Eser S; Gheorghiu R; Šekerija M; Trojanowski M; Žagar T; Zborovskaya A; Ryzhov A; Dessypris N; Morgenstern D; Petridou ET
Eur J Cancer; 2018 Jun; 96():44-53. PubMed ID: 29673989
[TBL] [Abstract][Full Text] [Related]
5. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
[TBL] [Abstract][Full Text] [Related]
6. [Clinical characteristics and prognostic analysis of 458 children with high-risk neuroblastoma in a single center].
Su Y; Ma XL; Wang HM; Qin H; Qin MQ; Zhang FQ; Jin M; Zhang DW; Chen CH; Zeng Q; He LJ; Ni X
Zhonghua Er Ke Za Zhi; 2020 Oct; 58(10):796-801. PubMed ID: 32987457
[No Abstract] [Full Text] [Related]
7. Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience.
Berlanga P; Pasqualini C; Pötschger U; Sangüesa C; Castellani MR; Cañete A; Luksch R; Elliot M; Schreier G; Kropf M; Morgenstern D; Papadakis V; Ash S; Ruud E; Brock P; Wieczorek A; Kogner P; Trahair T; Ambros P; Boterberg T; Castel V; Valteau-Couanet D; Ladenstein R
Eur J Cancer; 2021 Feb; 144():1-8. PubMed ID: 33316634
[TBL] [Abstract][Full Text] [Related]
8. Risk stratification of high-risk metastatic neuroblastoma: A report from the HR-NBL-1/SIOPEN study.
Morgenstern DA; Pötschger U; Moreno L; Papadakis V; Owens C; Ash S; Pasqualini C; Luksch R; Garaventa A; Canete A; Elliot M; Wieczorek A; Laureys G; Kogner P; Malis J; Ruud E; Beck-Popovic M; Schleiermacher G; Valteau-Couanet D; Ladenstein R
Pediatr Blood Cancer; 2018 Nov; 65(11):e27363. PubMed ID: 30015396
[TBL] [Abstract][Full Text] [Related]
9. Treatment outcomes among high-risk neuroblastoma patients receiving non-immunotherapy regimen: Multicenter study on behalf of the Thai Pediatric Oncology Group.
Suwannaying K; Monsereenusorn C; Rujkijyanont P; Techavichit P; Phuakpet K; Pongphitcha P; Chainansamit SO; Chotsampancharoen T; Winaichatsak A; Traivaree C; Sathitsamitphong L; Kanjanapongkul S; Komvilaisak P; Sanpakit K; Photia A; Seksarn P; Wiangnon S; Hongeng S;
Pediatr Blood Cancer; 2022 Sep; 69(9):e29757. PubMed ID: 35560972
[TBL] [Abstract][Full Text] [Related]
10. Distillation of the clinical algorithm improves prognosis by multi-task deep learning in high-risk Neuroblastoma.
Maggio V; Chierici M; Jurman G; Furlanello C
PLoS One; 2018; 13(12):e0208924. PubMed ID: 30532223
[TBL] [Abstract][Full Text] [Related]
11. Real World Experience of Treating Neuroblastoma: Experience from a Tertiary Cancer Centre in India.
Radhakrishnan V; Raja A; Dhanushkodi M; Ganesan TS; Selvaluxmy G; Sagar TG
Indian J Pediatr; 2019 May; 86(5):417-426. PubMed ID: 30778950
[TBL] [Abstract][Full Text] [Related]
12. Influence of image-defined risk factors on the outcome of patients with localised neuroblastoma. A report from the LNESG1 study of the European International Society of Paediatric Oncology Neuroblastoma Group.
Monclair T; Mosseri V; Cecchetto G; De Bernardi B; Michon J; Holmes K
Pediatr Blood Cancer; 2015 Sep; 62(9):1536-42. PubMed ID: 25663103
[TBL] [Abstract][Full Text] [Related]
13. [Treatment results of children with neuroblastoma: report of Polish Pediatric Solid Tumor Group].
Balwierz W; Wieczorek A; Klekawka T; Garus K; Bolek-Marzec K; Perek D; Swieszkowska E; Młynarski W; Stolarska M; Kowalczyk JR; Nurzyńska-Flak J; Balcerska A; Bień E; Wachowiak J; Januszkiewicz-Lewandowska D; Woźniak W; Raciborska A; Chybicka A; Ussowicz M; Krawczuk-Rybak M; Muszyńska-Rosłan K; Wysocki M; Kołtan S; Sobol G; Mizia-Malarz A; Urasiński T; Peregut-Pogorzelski J; Sońta-Jakimczyk D; Bubała H; Wieczorek M; Matysiak M; Sopyło B; Madziara W
Przegl Lek; 2010; 67(6):387-92. PubMed ID: 21344767
[TBL] [Abstract][Full Text] [Related]
14. [Report of Chinese Children's Cancer Group acute lymphoblastic leukemia 2015 multicenter study].
Chinese Children′s Cancer Group Acute Lymphoblastic Leukemia 2015 Study Group
Zhonghua Er Ke Za Zhi; 2022 Oct; 60(10):1002-1010. PubMed ID: 36207846
[No Abstract] [Full Text] [Related]
15. [Long-term follow-up of neuroblastoma in children less than 18 months of age].
Zhao J; Pan C; Xu M; Zhou M; Gao YJ; Hu WT; Tang JY
Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):754-759. PubMed ID: 29050113
[No Abstract] [Full Text] [Related]
16. Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study.
Perez CA; Matthay KK; Atkinson JB; Seeger RC; Shimada H; Haase GM; Stram DO; Gerbing RB; Lukens JN
J Clin Oncol; 2000 Jan; 18(1):18-26. PubMed ID: 10623689
[TBL] [Abstract][Full Text] [Related]
17. Localized resectable neuroblastoma: results of the second study of the Italian Cooperative Group for Neuroblastoma.
De Bernardi B; Conte M; Mancini A; Donfrancesco A; Alvisi P; Tomà P; Casale F; Cordero di Montezemolo L; Cornelli PE; Carli M
J Clin Oncol; 1995 Apr; 13(4):884-93. PubMed ID: 7707115
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for intermediate- or high-risk neuroblastomas in children in China.
Zhang Y; Zhang WL; Huang DS; Wang YZ; Hu HM; Zhi T; Mei YY
BMC Pediatr; 2023 Dec; 23(1):617. PubMed ID: 38053080
[TBL] [Abstract][Full Text] [Related]
19. Radical Surgery Improves Survival in Patients with Stage 4 Neuroblastoma.
Vollmer K; Gfroerer S; Theilen TM; Bochennek K; Klingebiel T; Rolle U; Fiegel H
World J Surg; 2018 Jun; 42(6):1877-1884. PubMed ID: 29127465
[TBL] [Abstract][Full Text] [Related]
20. Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology Group.
Teshiba R; Kawano S; Wang LL; He L; Naranjo A; London WB; Seeger RC; Gastier-Foster JM; Look AT; Hogarty MD; Cohn SL; Maris JM; Park JR; Shimada H
Pediatr Dev Pathol; 2014; 17(6):441-9. PubMed ID: 25207821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
